Latest Tri Locum Partners LP Stock Portfolio
$712Million | No. of Holdings #17
Tri Locum Partners LP Performance
2026 Q1+3.12%
YTD+3.12%
2025+17.81%
About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings
On 2026-05-18, the fund reported it's updated stock portfolio. In the 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $712.5 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Tri Locum Partners LP are JNJ, ISRG, TMO. The fund has invested 14.2% of it's portfolio in JOHNSON & JOHNSON and 9.9% of portfolio in INTUITIVE SURGICAL INC. <br><br> The fund managers got completely rid off DANAHER CORPORATION (DHR), BOSTON SCIENTIFIC CORP (BSX) and IONIS PHARMACEUTICALS INC (IONS) stocks. They significantly reduced their stock positions in DIANTHUS THERAPEUTICS INC, AXSOME THERAPEUTICS INC. (AXSM) and UNITED THERAPEUTICS CORP DEL (UTHR). Tri Locum Partners LP opened new stock positions in INTUITIVE SURGICAL INC (ISRG), THERMO FISHER SCIENTIFIC INC (TMO) and VERTEX PHARMACEUTICALS INC (VRTX). The fund showed a lot of confidence in some stocks as they added substantially to DEXCOM INC (DXCM), MADRIGAL PHARMACEUTICALS INC (MDGL) and NUVALENT INC (NUVL).
Tri Locum Partners LP Equity Portfolio Value
Last Reported on: 18 May, 2026
$712Million
as of May 18, 2026Tri Locum Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Tri Locum Partners LP made a return of 3.12% in the last quarter. In trailing 12 months, it's portfolio return was 25.48%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| intuitive surgical inc | 70,646,700 |
| thermo fisher scientific inc | 65,085,000 |
| vertex pharmaceuticals inc | 57,743,900 |
| jazz pharmaceuticals plc | 29,995,200 |
| tarsus pharmaceuticals inc | 17,719,000 |
| definium therapeutics inc | 6,985,210 |
New stocks bought by Tri Locum Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| dexcom inc | 65.6 |
| madrigal pharmaceuticals inc | 20.07 |
| nuvalent inc | 0.37 |
Additions to existing portfolio by Tri Locum Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| dianthus therapeutics inc | -76.62 |
| axsome therapeutics inc. | -69.19 |
| united therapeutics corp del | -41.8 |
| johnson & johnson | -31.28 |
| teva pharmaceutical inds ltd | -28.89 |
| argenx se | -15.98 |
| ascendis pharma a/s | -3.65 |
| eli lilly & co | -2.35 |
Tri Locum Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vera therapeutics inc | -40,800,100 |
| ionis pharmaceuticals inc | -44,078,000 |
| boston scientific corp | -49,630,400 |
| danaher corporation | -79,406,600 |
Tri Locum Partners LP got rid off the above stocks
Sector Distribution
Tri Locum Partners LP has about 85.9% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 85.9 |
| Others | 14.1 |
Market Cap. Distribution
Tri Locum Partners LP has about 77.5% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- MEGA-CAP
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| LARGE-CAP | 55.3 |
| MEGA-CAP | 22.2 |
| UNALLOCATED | 14.1 |
| MID-CAP | 8.4 |
Stocks belong to which Index?
About 71.5% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.
- S&P 500
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| S&P 500 | 55.5 |
| Others | 28.5 |
| RUSSELL 2000 | 16 |
Tri Locum Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Tri Locum Partners LP
Tri Locum Partners LP has 17 stocks in it's portfolio. About 81.6% of the portfolio is in top 10 stocks. LLY proved to be the most loss making stock for the portfolio. JNJ was the most profitable stock for Tri Locum Partners LP last quarter.
$712.55MTotal Value
21.00Positions
18 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 ARGX Argenx SeArgenx SeARGX | 3.24% | 31,635 | $23.10M 3.24% | 15.98%decreased 15.98 percentreduced | |
 ASND Ascendis Pharma A/SAscendis Pharma A/SASND | 8.2% | 255,332 | $58.40M 8.2% | 3.65%decreased 3.65 percentreduced | |
 Axsome Therapeutics Inc. Tri Locum Partners LP's holding in Axsome Therapeutics Inc. over time | 1.47% | 62,116 | $10.50M 1.47% | 69.19%decreased 69.19 percentreduced | |
 Boston Scientific Corp Tri Locum Partners LP's holding in Boston Scientific Corp over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Danaher Corporation Tri Locum Partners LP's holding in Danaher Corporation over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Dexcom Inc Dexcom IncDXCM Tri Locum Partners LP's holding in Dexcom Inc over time | 6.15% | 698,158 | $43.84M 6.15% | 65.6%increased 65.6 percentadded | |
 Ionis Pharmaceuticals Inc Tri Locum Partners LP's holding in Ionis Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Intuitive Surgical Inc Tri Locum Partners LP's holding in Intuitive Surgical Inc over time | 9.91% | 153,250 | $70.65M 9.91% | Newnew position | |
 Jazz Pharmaceuticals Plc Tri Locum Partners LP's holding in Jazz Pharmaceuticals Plc over time | 4.21% | 158,663 | $30.00M 4.21% | Newnew position | |
 Johnson & Johnson Tri Locum Partners LP's holding in Johnson & Johnson over time | 14.22% | 414,503 | $101.32M 14.22% | 31.28%decreased 31.28 percentreduced | |
 Eli Lilly & Co Tri Locum Partners LP's holding in Eli Lilly & Co over time | 7.98% | 61,795 | $56.84M 7.98% | 2.35%decreased 2.35 percentreduced | |
 Madrigal Pharmaceuticals Inc Tri Locum Partners LP's holding in Madrigal Pharmaceuticals Inc over time | 7.59% | 103,288 | $54.07M 7.59% | 20.07%increased 20.07 percentadded | |
 Nuvalent Inc Nuvalent IncNUVL Tri Locum Partners LP's holding in Nuvalent Inc over time | 4.44% | 308,506 | $31.61M 4.44% | 0.37%increased 0.37 percentadded | |
 Tarsus Pharmaceuticals Inc Tri Locum Partners LP's holding in Tarsus Pharmaceuticals Inc over time | 2.49% | 252,588 | $17.72M 2.49% | Newnew position | |
 Teva Pharmaceutical Inds Ltd Tri Locum Partners LP's holding in Teva Pharmaceutical Inds Ltd over time | 4.32% | 1,021,010 | $30.75M 4.32% | 28.89%decreased 28.89 percentreduced | |
 Thermo Fisher Scientific Inc Tri Locum Partners LP's holding in Thermo Fisher Scientific Inc over time | 9.13% | 132,413 | $65.08M 9.13% | Newnew position | |
 United Therapeutics Corp Del Tri Locum Partners LP's holding in United Therapeutics Corp Del over time | 5.86% | 70,370 | $41.73M 5.86% | 41.8%decreased 41.8 percentreduced | |
 Vera Therapeutics Inc Tri Locum Partners LP's holding in Vera Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Vertex Pharmaceuticals Inc Tri Locum Partners LP's holding in Vertex Pharmaceuticals Inc over time | 8.1% | 129,314 | $57.74M 8.1% | Newnew position | |
Com Dianthus Therapeutics IncDianthus Therapeutics Inc | 1.71% | 145,543 | $12.21M 1.71% | 76.62%decreased 76.62 percentreduced | |